Abstract |
Lascufloxacin exhibited a broad spectrum of activity against various clinical isolates. Furthermore, lascufloxacin showed the most potent activity against Gram-positive bacteria among the quinolones tested and incomplete cross-resistance against existing quinolone-resistant strains. Enzymatic analysis indicated that lascufloxacin had potent inhibitory activity against both wild-type and mutated target enzymes. These results suggest that lascufloxacin may be useful in treating infections caused by various pathogens, including quinolone-resistant strains.
|
Authors | Ryuta Kishii, Yuko Yamaguchi, Masaya Takei |
Journal | Antimicrobial agents and chemotherapy
(Antimicrob Agents Chemother)
Vol. 61
Issue 6
(06 2017)
ISSN: 1098-6596 [Electronic] United States |
PMID | 28320717
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 American Society for Microbiology. |
Chemical References |
- Anti-Bacterial Agents
- Fluoroquinolones
- lascufloxacin
|
Topics |
- Anti-Bacterial Agents
(pharmacology)
- Drug Resistance, Bacterial
- Escherichia coli
(drug effects, isolation & purification)
- Fluoroquinolones
(pharmacology)
- Humans
- Microbial Sensitivity Tests
- Staphylococcus aureus
(drug effects, isolation & purification)
- Streptococcus pneumoniae
(drug effects, isolation & purification)
|